Abstract Studies on the identification of the genetic basis for sexual dimorphism in peak bone mass are obviously important for providing novel therapeutic approaches to prevent or treat metabolic bone diseases. Our goal in this study was to identify the bone microstructure that could lead to differences in volumetric bone mineral density (vBMD) and new candidate genes that regulate the gender effect on bone. We used a congenic line of mice that carry the BMD1-4 locus from CAST/EiJ (CAST) mice in a C57BL/6J (B6) background and show greater vBMD in female, but not male, congenics compared to age-and gender-matched B6 mice. To assess the vBMD variations between the two lines of mice, we performed lCT measurements and found no difference in cortical bone volume by tissue volume (BV/TV) between congenics and B6 mice. However, trabecular BV/TV was significantly greater in female, but not male, congenics compared to corresponding B6 mice, which was due to increased trabecular thickness but not reduced trabecular separation, suggesting that bone formation, but not bone resorption, is responsible for the trabecular bone phenotype observed in the female, but not male, congenics. To identify the gender candidate genes, we determined the polymorphisms between B6 and CAST within the BMD1-4 locus and performed gene expression profiling. We identified EF-hand calcium binding domain (Efcab2), consortin, connexin sorting protein (Cnst), and presenilin 2 (Psen2) as potential candidate genes that regulate bone mass by influencing trabecular thickness in a gender-specific manner.
Introduction
Osteoporosis is a condition associated with decreased bone strength and increased fracture risk. Bone fractures are an important public-health problem, costing more than $17 billion each year [1] . It is estimated that one of three women and one of six men over the age of 50 years are expected to have bone fractures [2] . Thus, the prevalence of osteoporotic fractures is severalfold higher in women than in men. Therefore, an understanding of the mechanisms that contribute to increased fracture risk in women is important for establishing approaches to strengthening the bones in women in conditions where bone strength is compromised. The key factors that determine bone strength include bone mineral density (BMD), material properties, microarchitecture, and bone size [3] [4] [5] [6] [7] [8] . Furthermore, several studies have identified considerable variations in peak BMD among individuals and found that women with low peak BMD are more susceptible to osteoporosis than women with high peak BMD [9] . It is also now well established that the variation in peak BMD in both humans and experimental animals is largely determined by genetic factors. The heritable component for peak BMD variation is estimated to range between 50 and 90 % in humans and mice [10] [11] [12] [13] . Therefore, genetic studies on the identification of the genes involved in regulating peak BMD have recently received considerable attention based on the rationale that elucidation of genes and genetic pathways involved in the regulation of peak BMD could lead to the identification of novel targets for both diagnosis and treatment of osteoporotic patients.
Skeletal development, which is similar between males and females, takes a gender-specific course during puberty. Gender-specific differences in various skeletal parameters have been identified in both humans and experimental animals [14] [15] [16] . Accordingly, recent studies in humans have revealed a gender difference in the degree of heritability of BMD at specific skeletal sites [17, 18] . Studies in humans [19, 20] and both recombinant inbred [21, 22] and congenic [23, 24] strains of mice have revealed several quantitative trait loci (QTL) that exert gender-specific effects on femoral structure and peak BMD. Although these and other data provide convincing experimental evidence for the gender-specific effects of genetic loci on peak BMD, the identity of the gene(s) that confers the gender specificity remains to be established. In this regard, we used an intercross between high-volumetric BMD (vBMD) CAST and low-vBMD B6 mice to identify a QTL, namely, BMD1-4 in chromosome (Chr) 1, which regulates femoral vBMD in female, but not in male, mice [24] . The presence of a gene that confers a gender-specific effect on femoral vBMD has been confirmed using congenic mice in which the QTL region from CAST was transferred onto a B6 background [24] . Then, by superimposing the CAST chromosomal regions carried by three B6-CAST congenic lines of mice [24, 25] , we were able to narrow down the location of the BMD1-4 QTL, which has enabled us to screen for the candidate gene(s) that is responsible for the gender effect on bone mass and microarchitecture.
Materials and Methods

Animals
In this study we used a subcongenic line of mice, C175-185, that was generated previously [24] from congenic lines derived from two inbred strains of mice: lowvBMD B6 and high-vBMD CAST mice. B6 and CAST mice have been previously shown to differ widely in total femoral vBMD at 16 weeks of age [11] . These inbred strains of mice are highly polymorphic for genetic differences at more than 95 % of their genomes [26] , which made the fine mapping easy.
All animals were housed and maintained within the Veterinary Medical Unit of the Jerry L. Pettis Memorial VA Medical Center. All procedures were performed under humane conditions and approved by the Institutional Animal Care and Use Committee at the Jerry L. Pettis Memorial VA Medical Center (Loma Linda, CA).
A comparison of the genotyping data between the two subcongenic lines of mice and the C175-185 used in this study is displayed in Fig. 1 . Fig. 1 The regions of CAST Chr 1 transferred onto a B6 background for the three congenic sublines used to locate the BMD1-4 locus. Genotyping data for every marker are represented with ''B,'' referring to homozygous b6/b6, and ''C,'' referring to cast/cast. We present only some of the polymorphic markers used for genotyping. The names of the congenic sublines of mice are on the left. We used a ''C'' followed by the proximal and distal limits of CAST alleles carried by the congenic sublines in megabases (NCBI built 36). C180-184 did not show any difference in vBMD between congenic and B6 control mice [25] . C175-185 and C178-185 showed high vBMD in females but not males [24] . Subcongenic C180-184 and C178-185 lines of mice that have been previously generated [24, 25] are used here only to delimit the BMD1-4 QTL region, while C175-185 was used for all experiments in the study
Micro-Computed Tomographic Measurements
Cortical and trabecular bone microarchitectures of the femurs isolated from 16-week-old mice were assessed using microcomputed tomography (lCT) (VivaCt 40, l-CT scanner; Scanco, Bassersdorf, Switzerland). Femurs were scanned by X-ray, and the scanned image was then contoured to either include or exclude cortical bone. For trabecular bone parameters, slices chosen for analysis were based on the location of the growth plate and adjusted based on bone length, so the regions of interest chosen for trabecular and cortical bone parameters were anatomically the same between the congenics and the wild-type B6 control mice. An axial length of 180-190 slices (10.5 lm/slice) was analyzed at 0.336-0.399 mm proximal to the growth plate for distal femoral trabecular bone using the threshold setting of 200-1,000 mg/cm 3 . One hundred slices at the femur mid-diaphyseal region were analyzed for cortical bone using the threshold setting of 260-1,000 mg/ cm 3 . After image postprocessing, the bone volume-to-total volume ratio (BV/TV), trabecular thickness (Tb.Th), trabecular separation (Tb.S), and trabecular number (Tb.N) were calculated in the morphologic analysis.
Sixteen-week-old female and male mice were used in this study. Broken bones or bones that lost their growth plates were removed from the analyses. Thus, the numbers of animals that were used in lCT measurements were, for female B6, n = 13; female congenics, n = 11; male B6, n = 10; male congenics, n = 8.
Gene Expression
The quantification of mRNAs was performed by real-time RT-PCR using 500 ng total RNA derived from bone with bone marrow. RNA was extracted from femurs isolated from 14-week-old female congenics and age-and gendermatched B6 control mice. Trizol (Invitrogen Life Technologies, Carlsbad, CA) was used for RNA extraction following the manufacturer's protocol. Relative differences in expression between the groups were determined by RT-PCR using cycle time (Ct) values as follows: the Ct value of each gene of interest was normalized by the Ct values of two control genes of the same sample: 18S and peptidylprolyl isomerase A (PPIA). Then, the relative differences between groups were calculated and expressed as relative increases or decreases (fold change). Only the genes that showed the same difference trends between B6 and congenic mice after normalization by the 18S and PPIA control genes were considered as candidate genes. The primers used in this study are listed in Table 1 .
Statistical Analyses
We compared different skeletal parameters between males and females of the same line of mice and between B6 and congenic C175-185 mice in both genders using GraphPad Prism 5 (GraphPad Software, La Jolla, CA) and IBM SPSS 19 software (SPSS, Inc., Chicago, IL). We computed the difference between congenic and B6 male and female mice using a generalized linear model, with identity and log link and gaussian, gamma, and inverse gaussian distributions to account for both skewness in the data and the variance between groups. For each outcome variable, the model with the best fit based on the finite sample-corrected Akaiki information criteria (AICc) was selected in order to make the computations for that outcome variable. The AICc was used to take into account the small sample size 
of this study and the number of free parameters to estimate. We used the best model to measure the effect of gene type on the dependent outcome variable for all males and all females and to determine the gene and gender differences. P \ 0.05 indicated statistical significance.
Results
lCT Data
In our previous studies, using peripheral quantitative computed tomography, we found that female congenic C175-185 mice that carry the BMD1-4 locus from CAST mice show a greater total femoral vBMD compared to ageand gender-matched B6 control mice, while male congenics did not show a difference in vBMD compared to corresponding B6 control mice [24] . In this study, we used congenic C175-185 mice and B6 control mice to investigate the sexual dimorphism in femoral bone parameters.
We first compared bone parameters between males and females of same line of mice using lCT measurements at the femoral mid-diaphysis and at the distal metaphysis. Since total femoral vBMD variations have been identified in 16-week-old mice [24] , lCT measurements were also performed at 16 weeks of age. As expected, total volume (TV) as well as bone volume (BV) at both the middiaphysis and the distal femoral metaphysis were significantly reduced in female compared to male mice for both B6 and congenic mice (Fig. 2 , Table 2 ). While a significant difference in TV and BV was found at both the femoral mid-diaphysis and metaphysis between female congenics and corresponding B6 control mice, no differences were found between the two lines of male mice (Fig. 2 , Table 2 ). BV/TV was similar in both male and female mice of both strains at the femoral mid-diaphysis ( Fig. 3a ; Table 2 ). However, at the metaphysis, the ratio Tb.BV/TV was significantly reduced in B6 female mice compared to corresponding male mice ( Fig. 3b; Table 2 ). Comparison of trabecular bone parameters between congenics and B6 control mice revealed a significant increase in Tb.BV/TV at the distal femoral metaphysis in female congenics ( Fig. 3b ; P = 0.003) compared to age-and gender-matched B6 control mice. Among male mice, no significant difference in Tb.BV/TV was observed between congenic mice and corresponding B6 mice ( Fig. 3b; Table 2 ).
A reduction in Tb.N ( Fig. 4a ; Table 2 ) and a significant increase in Tb.S ( Fig. 4c ; Table 2 ) were observed in female mice compared to corresponding male mice for both B6 and congenic mice. However, no difference in Tb.N or Tb.S was observed between congenic and B6 control mice in both genders (Fig. 4a, c; Table 2 ). Tb.Th was significantly reduced ( Fig. 4b; Table 2 ) in femurs derived from female B6 mice compared to male mice but not between males and females within the congenic line of mice ( Fig. 4b; Table 2 ). While congenic female mice showed significantly greater Tb.Th compared to corresponding B6 control mice, no difference was observed between the two lines of mice within male mice ( Fig. 4b; Table 2 ).
Screen for the Gender Candidate Genes
By superimposing the CAST chromosomal regions carried by three B6-CAST congenic lines of mice [24, 25] , we were able to narrow down the location of the BMD1-4 QTL to a small area of *3.1 Mb in the region D1mit115-D1mit509 (Fig. 1) . In order to identify the candidate gene(s) that might be responsible for the gender difference in BV and Tb.Th between congenics and the B6 control mice, we first used the mouse genome database from the National Center Biotechnology Information (NCBI) to identify the genes that underlie the BMD1-4 locus region. Our search revealed evidence of the presence of 34 genes/ ESTs in this region (Table 3) . We next searched the Phenome Database to identify the sequence variations between B6 and Cast within the BMD1-4 locus. We chose this data set since it includes SNP information from not only Sanger1 but also other sources including Perlegen2, Broad2 and -1, and Merck. This search led to the identification of 16 genes and predicted genes that showed nonsynonymous (n) SNPs between the two strains of mice (Table 4) . We next compared mRNA expression between B6 and congenic female mice of the genes that show nSNPs between B6 and CAST mice (Table 5) . Among the 16 genes, only three genes showed differential expression between female congenic and corresponding B6 mice. The EF-hand calcium binding domain 2 (Efcab2) and presenilin 2 (Psen2) genes were downregulated in femurs derived from female congenics (0.45-and 0.2-fold, respectively) compared to age-and gender-matched B6 mice (Table 5 ), while consortin, connexin sorting (Cnst) gene expression was greater (1.6-fold, P \ 0.05) in femurs derived from female congenic mice compared to age-and gender-matched B6 mice (Table 5 ).
Discussion
Studies in humans have revealed a higher heritability of BMD in mother-daughter and father-son pairs than across sexes [17, 27, 28] . However, only a few studies in humans have recently identified gender-specific BMD QTL [19, 20] . In contrast, several studies using recombinant inbred strains of mice [21] and congenic mice [22, 24] have revealed QTL that exert gender effects on femoral structure and peak BMD. In our previous studies, using molecular genetic approaches, we narrowed the size of a gender-specific QTL in Chr 1 to a region small enough that allowed us to proceed with the gene identification process. Because this region is syntenic to human Chr 1, which contains a BMD QTL [29] , there is a high likelihood that the gene identified in mice may also be relevant to humans. In this study, we used a congenic that carries a CAST chromosomal region that covers the BMD1-4 locus [24] to identify the candidate genes responsible for the gender effect on trabecular bone volume and thickness between female congenics and gender-matched B6 control mice.
Previous bone studies have demonstrated that ovariectomy reduced trabecular BMD but estrogen substitution of ovariectomized mice restored this effect [30] [31] [32] . Furthermore, using high-resolution 3-T MRI in healthy people, Alberich-Bayarri et al. [33] demonstrated that Tb.BV/TV and Tb.Th are influenced by gender in humans. In the present study, as expected, B6 mice showed a gender effect on all trabecular bone parameters. However, in congenic mice the gender effect on Tb.BV/TV and Tb.Th was significantly reduced compared to B6 mice, which suggests that the CAST gene(s) carried by congenic mice alters the Lin-9 homolog (Caenorhabditis elegans) Lin9 Mix1 homeobox-like 1 (Xenopus laevis) Mixl1 Acyl-Coenzyme A binding domain containing 3 Acbd3 H3 histone, family 3A H3f3a
The region displayed is located at 179,610 K-182,730 K bp (Build 37.2) Efcab2, a potential candidate gene, represents the largest family within the superfamily of proteins that carry the Cabinding EF-hand motif and was shown to be a mechanoresponsive gene in human osteoblast cells [34] . In the present study, Efcab2 was found to be downregulated in female congenic mice ( Table 5 ). The difference in the expression could be due to the nSNPs that were found in the Efcab2 functional domain and could affect the conformation and the chemical properties of the protein and, consequently, its function as well as the expression of the gene. If the observed genetic variation in Efcab2 is the cause for the gender difference in Tb.BV and microarchitecture in the congenic mice, that means that Efcab2 participates in mediating the sex hormone effect, which needs to be investigated in future studies. Psen2, a potential candidate gene, is expressed in osteoblast cells and has been found to be upregulated during late-stage osteoblast differentiation [35] . Engin et al. [36] showed that mice lacking both presenilin-1 (Psen1) and Psen2 exhibited impaired Notch signaling in osteoblasts and late-onset, agerelated osteoporosis. Psen1
-/-and Psen2 -/-mice showed an increase in osteoblast-dependent osteoclastic activity, in part due to decreased osteoprotegerin mRNA expression in osteoblast cells and a reduction in Tb.N compared to wildtype control mice [36] . However, congenic C175-185 mice with reduced Psen2 expression compared to gendermatched B6 control mice exhibited greater Tb.Th but no difference in Tb.N. Whether the difference in skeletal phenotype of congenic mice compared to Psen1 -/-and Psen2 -/-mice is due to a compensatory increase in Psen1 expression remains to be examined. Data are presented as fold change between female congenic and gender-and age-matched B6 mice and are mean ± SD, n = 6-7
Bold indicates significance. *P \ 0.05 vs. corresponding B6 mice Cnst is an integral membrane protein that acts as a binding partner of connexins, the building blocks of gap junctions, and as a trans-Golgi network receptor involved in connexin targeting to the plasma membrane and recycling from the cell surface. The Cnst gene is expressed in preosteoblast cells [37] . It was downregulated in mutants lacking estrogen-related receptor alpha (Erralpha) [38] , thus suggesting that the Cnst gene is involved in the Erralpha pathway. The nSNPs in the Cnst gene that have been found between B6 and CAST could affect the conformation of the protein and cause the difference in the expression found between B6 and congenic mice. Thus, analyzing the role of Cnst on bone volume and microarchitectural variations could provide more insight on how Erralpha regulates bone strength.
A potential limitation of this study is that in our first screen for gender candidate genes we considered only genes that show nSNPs between B6 and CAST mice. However, since SNPs at the intervening sequence may also affect the gene expression and, consequently, protein function, it is still necessary to investigate the SNPs at the promoters and intervening sequences as well as the expression of the remaining BMD1-4 genes that are highly expressed in bone to determine if the BMD1-4 locus carries additional candidate genes that contribute to trabecular variations between female congenics and female B6 control mice. Analyzing the interactions between all of the candidate genes is critical to understanding the mechanisms that contribute to gender effects on bone mass.
Conclusions
Our first screen for gender specificity candidate genes within the BMD1-4 locus led to the identification of three candidate genes, Efcab2, Cnst, and Psen2, that exhibit differential expression between female congenic mice and corresponding B6 mice and nSNPs that distinguish B6 from CAST mice. These data suggest that one or more genes and their interaction could be responsible for the increase in Tb.BV/TV and Tb.Th observed in congenic female mice compared to gender-matched B6 mice. Further studies are needed to determine the mechanism by which the candidate gene(s) affects trabecular thickness.
